Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erector Spinae Plane Block for Rib Fractures
NCT04916691Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- May 2021
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ropivacaine in rib fracture, sponsored by Mayo Clinic. Primary endpoint: Procedural success rate at 12 months. Started May 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
rib fracture
Beyond the preview
Go deeper on NCT04916691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04916691.